Targeting therapy to minimize antimicrobial use in preweaned calves: effects on health, growth, and treatment costs.
Prophylactic and therapeutic antimicrobial use in food animals is questioned because of the potential for development of resistant bacteria and future inability to use some antimicrobials for human or animal disease. The objectives of this study were to determine the effect of raising preweaned dairy calves without antimicrobials in the milk and minimizing therapeutic antimicrobial treatment on morbidity, mortality, weight gain, and treatment costs. Newborn calves (n = 358) were allocated to 1 of 4 groups, housed outdoors in individual hutches, and monitored for 28 d. Calves in the conventional therapy (CT) group were treated as per dairy protocol with sulfamethoxazole/trimethoprim, spectinomycin, penicillin, and bismuth-pectin for diarrhea. The targeted therapy (TT) group included bismuth-pectin for diarrhea and antimicrobial treatment only in cases of fever or depressed attitude. Within CT and TT groups, calves were equally assigned to receive neomycin and tetracycline in their milk for the first 2 wk of life (AB-milk) or no antimicrobials (NoAB-milk). Daily health evaluations included fecal consistency, respiratory disease, attitude, and hydration status as well as milk and grain consumption. A negative binomial model evaluated the total number of days with diarrhea days in each group. General linear models were used to assess average daily weight gain and grain consumption. Conventionally treated calves had 70% more days with diarrhea than TT calves, and AB-milk calves had 31% more days with diarrhea compared with NoAB-milk calves. The TT calves tended to have a higher average daily gain by 28 d and consumed more grain compared with CT calves. If antimicrobials were used only for diarrhea cases with fever, inappetence, or depression and no in-milk antimicrobials were used, a $10 per calf savings could be realized. Targeting antimicrobial therapy of calf diarrhea cases is prudent not only to save the drugs for future use but also to prevent the potential for antibiotic-associated diarrhea and reduce calf-rearing costs.
Berge
A C B
AC
Berge Veterinary Consulting, Helsingborg, Sweden.
Moore
D A
DA
Besser
T E
TE
Sischo
W M
WM
D000818:Animals; D000833:Animals, Suckling; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001835:Body Weight / Q000502:physiology; D002417:Cattle / Q000254:growth & development; D002418:Cattle Diseases / Q000188:drug therapy* / Q000191:economics*; D003612:Dairying / Q000191:economics* / Q000379:methods*; D003967:Diarrhea / Q000188:drug therapy / Q000191:economics / Q000662:veterinary*; D004435:Eating / Q000502:physiology; D005260:Female; D008297:Male; D013997:Time Factors
D000890:Anti-Infective Agents